Lymphoid Neoplasm — Trials

Lymphoid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8,886 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,419
Recruiting: 1,267
Ph III recruiting: 131
Growth YoY: +4%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,374)

clinicaltrialsPublishedShowing 401–450 of 2,909 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04664179	EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma(CILESTE)	recruiting	Phase 1	52	Baylor College of MedicineOTHER	1	Jun 25, 2026	clinicaltrials
NCT06447376	Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab	recruiting	Phase 1	20	Taylor BrooksOTHER	1	Jun 25, 2026	clinicaltrials